BNP Paribas Knock-Out MRK 17.05.2.../ DE000PC41EL2 /
2024-05-16 5:20:43 PM | Chg.+0.250 | Bid5:37:09 PM | Ask5:37:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
9.800EUR | +2.62% | 9.550 Bid Size: 1,048 |
10.000 Ask Size: 1,000 |
MERCK KGAA O.N. | - EUR | 2024-05-17 | Call |
GlobeNewswire
12:00 AM
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-15
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VIS...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA